Comparison of Fixed-Dose Inhaled Epoprostenol and Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome in Critically Ill Adults.
Mitchell S BuckleySumit K AgarwalRoxanne Garcia-OrrRajeev SaggarRobert MacLarenPublished in: Journal of intensive care medicine (2020)
Fixed-dose iEPO was comparable to iNO in patients with moderate-to-severe ARDS for oxygenation and ventilation parameters as well as clinical outcomes. Significant cost-savings were realized with iEPO use.